Information  X 
Enter a valid email address

Medica Group PLC (MGP)


Friday 19 March, 2021

Medica Group PLC

Microsoft Research's Dr Junaid Bajwa joins as NED

RNS Number : 7890S
Medica Group PLC
19 March 2021

19 March 2021


Medica Group Plc


Medica appoints Microsoft Research's Chief Medical Scientist as Non-Executive Director


Medica Group Plc (LSE: MGP, "Medica" or the "Company"), the market leader in the provision of teleradiology services in the UK and Ireland, announces that Dr Junaid Bajwa will join the Board of Medica as a Non-Executive Director and Chair of the Clinical and Risk Committee on the 1st April 2021.


Junaid is a highly skilled individual who brings a wealth of experience with him in his new role at Medica. Junaid is a practicing physician in the NHS and currently occupies the roles of Chief Medical Scientist at Microsoft Research, and as a Non-Executive Director at University College London Hospitals NHS Foundation Trust. He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme (Merck & Co), where he helped shape their global digital strategy.   Junaid also has experience in the academic world where he is a Clinical Associate Professor at University College London (UCL), and a Visiting Scientist at the Harvard School of Public Health.


Over the past 15 years, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer, and policy maker within the UK, where he specialised in informatics, digital transformation, and leadership. He has also acted as a consultant for health care systems across the US, Australia, New Zealand, Singapore, the Middle East, and Europe. No further details are required to be disclosed under LR 9.6.13.


Roy Davis, Chairman of Medica, said:

"We are delighted to have someone of Junaid's experience join the Board. His clinical expertise coupled with his digital healthcare and commercial experience will be of enormous benefit to Medica as we continue to expand our technological and telemedicine service offerings internationally. I very much look forward to working with him."


Commenting on his appointment, Dr Junaid Bajwa added:

"I am very pleased to be joining the board of an exciting and rapidly-growing company. Medica has a compelling strategy in place which speaks directly to my clinical and digital healthcare skill set. I am looking forward to engaging with the Board and the management team and using my expertise to help implement this strategy."


For further information, please contact:  


Medica Group Plc:

Roy Davis, Chairman

Stuart Quin, Chief Executive Officer


+44 (0)33 33 111 222


Investec Bank plc (Joint Broker)

Sara Hale

Daniel Adams

Virginia Bull


+44 (0)20 7597 5970

Liberum (Joint Broker)

Bidhi Bhoma

Richard Lindley


+44 (0)20 3100 2000

FTI Consulting

Victoria Foster Mitchell

Sam Purewal


+44 (0)20 3727 1000


About Medica Group PLC


Medica is the market leader in the UK and Ireland for the provision of teleradiology services, providing outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerised tomography), ultrasound and plain film (x-ray) images, and the market leader for the provision of retinal diagnostic screening in Ireland. The Company currently offers two primary services to hospital radiology departments:


· NightHawk, urgent reporting service, and

· Elective which includes routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.


Medica contracts with the largest pool of consultant radiologists in the UK [and Ireland], performing remote access teleradiology across its customer base of more than 100 NHS Trusts in the UK, the Irish HSE, private hospital groups and diagnostic imaging companies. This enables the Company to offer a fast, responsive service both during the day and importantly supporting urgent out-of-hours reporting.


Medica has developed a bespoke, secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and consultant radiologists who contract with the Company. Direct RIS access ensures that where the wider patient medical history is available, it can be reviewed by the consultant as part of every report. For more information please visit  





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t